NEW YORK (GenomeWeb News) – Accelerate Diagnostics said today it raised $45 million from a rights offering commenced last month.

About $25.5 million was raised from shareholders who subscribed for more than 1.5 million shares of the Tucson, Ariz.-based firm's common stock. It said that approximately 58 percent of the shares were subscribed for by Accelerate's directors, and added that 57 percent of stockholders exercised their subscription privileges.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.